華北製藥(600812.SH):收到政府土地收儲出讓收益返還款2076.83萬元
格隆匯 8 月 5日丨華北製藥(600812.SH)公佈,2020年8月4日,公司收到石家莊市土地儲備中心撥付的土地收儲補償費20,768,343.9元。上述土地為公司位於長安區豐收路142號院內(7號井),面積為4658.5平方米,國有建設用地使用權於2019年5月13日由石家莊市公共資源交易中心組織進行公開出讓。受讓人為河北潤滹房地產開發有限公司,成交價款為4402.4萬元。
根據《企業會計準則》及《企業會計準則解釋第3號》相關規定,公司將本次收到的資金衝減其他應收款-石家莊市國土資源局491,278.42元,衝減其他應收款-搬遷停工損失20,277,065.48元,不影響公司當期損益。具體會計處理須以會計師審計確認後的結果為準。公司將密切關注其他土地的進展情況,並嚴格按照相關法律法規及時履行信息披露義務。敬請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.